Showing results (21-30 of 728) with videos related to
Sort By:
Pageof 73
Vascular Health and Risk Management|April 15, 2011
Olmesartan medoxomil for the treatment of hypertension in children and adolescentsGiuliano Tocci, Massimo VolpeAmerican Journal of Hypertension|June 17, 2011
Redefining blood pressure targets in high-risk patients?: lessons from coronary endpoints in recent randomized clinical trialsMassimo Volpe, Giuliano TocciCardiology|May 3, 2013
Plasma renin and cardiovascular risk: what is the evidence for an association?Massimo Volpe, Thomas UngerDrugs & Aging|October 31, 2013
Olmesartan in the treatment of hypertension in elderly patients: a review of the primary evidenceMassimo Volpe, Giuliano TocciInternational Journal of Molecular Sciences|August 21, 2019
Natriuretic Peptides in the Cardiovascular System: Multifaceted Roles in Physiology, Pathology and TherapeuticsSperanza Rubattu, Massimo VolpeCardiovascular Therapeutics|October 26, 2018
Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartanStefano Omboni, Massimo VolpeIntegrated Blood Pressure Control|March 30, 2012
New treatment options in the management of hypertension: appraising the potential role of azilsartan medoxomilMassimo Volpe, Carmine SavoiaAging Clinical and Experimental Research|April 28, 2006
Integrated cardiovascular risk management for the future: lessons learned from the ASCOT trialMassimo Volpe, Giuliano TocciExpert Review of Cardiovascular Therapy|August 4, 2011
Fixed-combination therapy to improve blood pressure control: experience with olmesartan-based therapyGiuliano Tocci, Massimo VolpeHeart International|October 7, 2011
Discovering a new role for the atrial natriuretic peptide: A novel risk factor for cardiovascular diseasesSperanza Rubattu, Massimo VolpePageof 73